Close this search box.

Doug Williams leaving Sana

ARTICLE | Management Tracks

Plus: Baptista joins SmartCella and updates from LifeArc and Gain

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

April 19, 2024 9:50 PM UTC

Cell therapy company Sana Biotechnology Inc. (NASDAQ:SANA) announced in an SEC filing the departure of EVP and President, R&D Doug Williams. The company did not disclose a successor to Williams, who joined Sana last April. Williams was co-founder and CEO of exosome company Codiak Biosciences Inc. (NASDAQ:CDAK) before joining Sana. Before Codiak, he served as EVP of R&D at Biogen Inc. (NASDAQ:BIIB).

SmartCella Holding AB, which is developing stem cell and RNA-based therapies, hired Ricardo Baptista as CTO. Baptista was CTO at Alder Therapeutics AB. …